Model predictive control of type 1 diabetes: an in silico trial
about
Treating type 1 diabetes: from strategies for insulin delivery to dual hormonal controlClosed-loop insulin delivery for treatment of type 1 diabetesRecent developments in clinical trial designs for HIV vaccine researchEffect of canagliflozin on renal threshold for glucose, glycemia, and body weight in normal and diabetic animal modelsPharmacokinetic Model of the Transport of Fast-Acting Insulin From the Subcutaneous and Intradermal Spaces to BloodModular closed-loop control of diabetesMulticenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes.Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites.Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-managementAlgorithms for a closed-loop artificial pancreas: the case for model predictive control.Algorithms for a closed-loop artificial pancreas: the case for proportional-integral-derivative controlArtificial pancreas: model predictive control design from clinical experienceDiAs web monitoring: a real-time remote monitoring system designed for artificial pancreas outpatient trialsDiAs user interface: a patient-centric interface for mobile artificial pancreas systemsA closed-loop artificial pancreas using a proportional integral derivative with double phase lead controller based on a new nonlinear model of glucose metabolismDiabetes technology: markers, monitoring, assessment, and control of blood glucose fluctuations in diabetes.Artificial pancreas: past, present, futureAP@home: a novel European approach to bring the artificial pancreas home.A controlled study of the effectiveness of an adaptive closed-loop algorithm to minimize corticosteroid-induced stress hyperglycemia in type 1 diabetes.A closed-loop artificial pancreas based on risk management.Combining basal-bolus insulin infusion for tight postprandial glucose control: an in silico evaluation in adults, children, and adolescentsMultinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results.Impact of blood glucose self-monitoring errors on glucose variability, risk for hypoglycemia, and average glucose control in type 1 diabetes: an in silico study.Diabetes: Models, Signals, and Control.Control to range for diabetes: functionality and modular architecture.Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experienceRun-to-run tuning of model predictive control for type 1 diabetes subjects: in silico trial.In silico preclinical trials: methodology and engineering guide to closed-loop control in type 1 diabetes mellitus.Physical activity into the meal glucose-insulin model of type 1 diabetes: in silico studies.Evaluating the efficacy of closed-loop glucose regulation via control-variability grid analysisIn silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes.Modeling the error of continuous glucose monitoring sensor data: critical aspects discussed through simulation studies.MD-logic artificial pancreas system: a pilot study in adults with type 1 diabetes.Insulin patch pumps: their development and future in closed-loop systems.Pharmacodynamic effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, from a randomized study in patients with type 2 diabetes.Automated control of an adaptive bihormonal, dual-sensor artificial pancreas and evaluation during inpatient studies.Development of a multi-parametric model predictive control algorithm for insulin delivery in type 1 diabetes mellitus using clinical parametersMultiple-Input Subject-Specific Modeling of Plasma Glucose Concentration for Feedforward Control.Closed-loop insulin delivery in type 1 diabetes.Validation of a novel method for determining the renal threshold for glucose excretion in untreated and canagliflozin-treated subjects with type 2 diabetes mellitus.
P2860
Q26853250-39AF26A0-D7BB-4D6F-A8BF-28FF0CACD434Q27008127-7DA87255-DDFD-4847-BD75-7920A939A720Q28083514-E4F90780-C86A-40C2-BEE5-6A2E52619621Q28732080-AB7CD549-EBCC-449B-B593-3D5111CBE155Q30300391-214D0E03-3BC6-497A-8E8F-486CB5B11C7CQ30370427-75B9CA20-8A4B-4B0E-B4DA-446A2BCE425BQ30370610-F6E30311-CE4E-4447-9998-99172AC43BA5Q30370613-7E14756F-F796-4B45-A732-D1C16D6FE731Q30409243-5CCF4DBE-9081-4A5F-92A7-7774DCD4BECDQ30409797-D98629F7-4250-4325-A5B6-DE5F2A0F4A72Q30409801-53E8D282-5040-4105-939A-5078777511B7Q30409808-FC093CCB-E71F-4FC6-A0A8-8A38294F0CD8Q30409819-9E832684-9B5B-4BF3-886C-1A3426CA615AQ30409823-4D194B12-C0F1-4686-95A6-A1317E7FF83EQ30413389-C605FF02-EA26-4824-9B23-E5E3965CDEA4Q30416241-15E39064-33BC-492E-B86F-ED9F86767A03Q30424200-8B15337C-16D3-44DF-8708-E770E463CF5DQ30424293-949DE048-F637-40D4-984C-D992BB9E8022Q30424305-688FF4D1-67F3-42A4-9D53-0307A79AF864Q30428124-2EF87B05-839D-49A0-B479-290B6454AA98Q30429984-6F31397D-F443-44D9-96A0-E8C3635C79F9Q30429989-CCC32C03-0CDD-48EE-A341-3EA818E2FED9Q30432525-2697892A-B341-4E2F-8B55-189D755C6638Q30434551-061B72C5-E879-45F3-A070-F5846C78251AQ30434937-B5FE950C-361F-42F9-9612-259E617C0ED8Q30434939-F0BA6A47-E0EE-47A5-825E-8947E7B05523Q30434940-134C5A73-EC2D-4360-96BA-23DA7F554297Q30436935-6B15D36C-8BE5-40D9-A221-2DAD4A1BFBB3Q30437503-1B195A3B-5F70-422C-ACCC-21D13E65DD49Q30437978-823DC794-28BF-4922-A7CA-4A38BB6B5661Q30439654-C29E4B6E-5BFA-45A4-B0D2-01B38B5D70ACQ33532319-5EB65B2C-559C-4503-8CC5-2F4E8E054209Q33804654-2A29F435-64E0-40A4-9E26-F06FEA91A16EQ34076632-4B17945F-1983-44DB-95D3-7E30A9D6DD17Q34105064-98A19C94-FEE1-464D-9B8F-C8FCB610FB5BQ34243374-C607C882-7026-4A5B-9FFB-4A04DE079895Q34812164-3C583AF4-E2D5-4A17-B1BD-5236B88A8BB7Q34986246-0F364433-C181-4DF5-9A41-0946D813DEC1Q35954124-BC165299-5427-4917-8E8E-0364E8976B7CQ36997767-F51B0138-702D-496A-B037-B80E38D10E9B
P2860
Model predictive control of type 1 diabetes: an in silico trial
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Model predictive control of type 1 diabetes: an in silico trial
@ast
Model predictive control of type 1 diabetes: an in silico trial
@en
type
label
Model predictive control of type 1 diabetes: an in silico trial
@ast
Model predictive control of type 1 diabetes: an in silico trial
@en
prefLabel
Model predictive control of type 1 diabetes: an in silico trial
@ast
Model predictive control of type 1 diabetes: an in silico trial
@en
P2093
P2860
P1476
Model predictive control of type 1 diabetes: an in silico trial
@en
P2093
Boris Kovatchev
Davide M Raimondo
Giuseppe De Nicolao
Lalo Magni
Luca Bossi
P2860
P304
P356
10.1177/193229680700100603
P577
2007-11-01T00:00:00Z